Engineered Microbial Routes for Human Milk Oligosaccharides Synthesis.

Area of Science:

• Biotechnology
• Microbiology
• Biochemistry

Background:

• Human milk oligosaccharides (HMOs) are crucial for infant health.
• Microbial production offers a scalable, cost-effective alternative to traditional methods.
• Advances in metabolic engineering enhance HMO synthesis efficiency.

Purpose of the Study:

• To review recent advancements in microbial production of HMOs.
• To highlight challenges and strategies in host strain selection and metabolic pathway engineering.
• To discuss the critical role of glycosyltransferases in HMO synthesis.

Main Methods:

• Utilizing engineered microbial systems for HMO production.
• Employing metabolic engineering strategies to optimize production pathways.
• Investigating glycosyltransferase expression for specific HMO synthesis.

Main Results:

• Successful microbial production of various HMOs, including 2'-fucosyllactose (2'-FL).
• 2'-FL is the most abundant HMO produced via engineered routes.
• Challenges remain in host strain selection and metabolic pathway optimization.

Conclusions:

• Engineered microbial routes are promising for large-scale HMO production.
• Optimizing host strains and glycosyltransferases is key for efficient synthesis.
• Further research is needed to overcome limitations in metabolic pattern uncertainty.